secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-04-24T23:59:59+00:00
Accession:  0001575872-23-000606
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition Corp. enters $50M common stock purchase agreement with White Lion Capital
--------------------------------------------------------------------------------

- Up to $50M in common stock may be sold to White Lion at 97% of VWAP post-business combination with Estrella Biopharma.
- Commitment fee of 250,000 shares of Estrella Series A Preferred Stock valued at $250,000 to be issued to White Lion.
- Investor may terminate if registration statement lapses for 45 consecutive trading days or other material breaches.
- Purchase price adjusts to 98% of VWAP after $25M of shares purchased.
- Company must register shares for resale within 30 days of business combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/0001575872-23-000606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/uptd-20220419.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer